Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Protagonist Therapeutics, Inc. (PTGX) News - StockMarketCap

Stocks›Protagonist Therapeutics, Inc.☆

● At closeAs of Jul 2, 2026

Protagonist Therapeutics, Inc.

PTGX✓

HealthcareBiotechnologyNASDAQ

$131.62+5.15%

$8.46BMarket cap

-68.89xP/E ratio

641.27KVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$131.62

$6.45 (+5.15%) · 24h

Key metrics

Market cap$8.46B+29.14%

Enterprise value$7.80B

Volume (24h)641.27K

P/E ratio (TTM)-68.89x

P/S ratio (TTM)107.79x

Dividend yield0.00%

Shares outstanding64.31M

Trading range

Previous close$125.17

Day range$125.24 - $131.84

52-week range$49.38 - $126.59

Protagonist Therapeutics, Inc. (PTGX) operates in the Biotechnology industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news